(Q34626067)

3 August 2017

1 reference

title

Alzheimer's disease and oxygen radicals: new insights (English)

1 reference

3 August 2017

0 references

Domenico Praticò

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

3 August 2017

published in

Biochemical Pharmacology

1 reference

3 August 2017

volume

63

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

563-567

1 reference

Molecular basis of the neurodegenerative disorders

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Translating cell biology into therapeutic advances in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

In vivo measurement of the redox state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Oxidative stress in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Oxidative stress and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

The measurement and mechanism of lipid peroxidation in biological systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

The isoprostanes in biology and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Antioxidants, oxidative stress, and degenerative neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Lipid peroxidation and free radical scavengers in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Increased CSF F2-isoprostane concentration in probable AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

The neurobiologic consequences of Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Transgenic mouse models of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900919-4

10.1016/S0006-2952(01)00919-4

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference